Healthtech Startups

Voiceitt provides real-time captioning for Microsoft Teams that supports non-standard speakers, including people with speech disabilities, Deaf individuals, and those with accented English. The company builds voice AI technology to make speech recognition accessible to underrepresented speaker populations.

7 investors

Vori Health is a nationwide specialty medical practice that treats back, neck, and joint pain using board-certified orthopedic specialists and integrated care teams. The company provides telemedicine and in-person care to reduce misdiagnosis, ineffective therapies, and unnecessary surgeries.

7 investors

Vynca provides palliative care services and advance care planning software for people living with life-limiting illness, delivered across multiple states through clinical teams and digital tools. The company combines clinical expertise with technology to enable flexible, patient-centered care outside traditional healthcare facilities.

7 investors

Vyv develops UV-free, chemical-free antimicrobial lighting technology using visible spectrum LEDs that continuously reduce microbial growth in occupied indoor spaces. The company serves healthcare, travel, food and beverage, agriculture, and fitness industries with integrated solutions designed for always-on protection in buildings and environments.

7 investors

Walrus Health is an AI-powered clinical pharmacy platform that helps mid-to-large self-insured employers and school districts optimize prescription medications for employees with chronic conditions. The platform pairs employees identified by AI with clinical pharmacists to reduce medication costs and improve health outcomes.

7 investors

Waymark builds an AI-powered clinic model for Medicaid populations, using predictive analytics and clinical decision support to identify at-risk patients and coordinate community-based care. The company works with health plans and health systems to improve health outcomes and reduce costs for underinsured populations.

7 investors

Welcome Tech provides services and support to help immigrants establish themselves in a new country and navigate life in America. The platform combines community resources and tailored solutions to address the comprehensive needs of immigrants.

7 investors

Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions. The company serves healthcare providers, health plans, and patients seeking evidence-based, technology-enabled chronic care management.

7 investors

Wellumio develops axana®, a portable, energy-efficient MRI system based on its Pulsed Gradient Free Mapping (PGFM) technology, designed to detect acute stroke quickly in front-line care settings. The product targets stroke diagnostics and brain imaging workflows in medical and critical care environments.

7 investors

Xandar Kardian uses ultra-wideband (UWB) radar sensors to monitor human vital signs and building occupancy, serving healthcare providers for continuous, contactless vital signs monitoring and building owners and operators for real-time occupancy data and people counting. The company operates in health monitoring and property technology.

7 investors

Zone7 develops data and AI-powered products to optimize performance and durability for high-performance teams. The company serves organizations seeking to elevate team performance through data-driven insights and artificial intelligence.

7 investors

Zus provides a platform that removes data waste in healthcare, enabling developers, clinicians, and operators to innovate in patient and care team experience without building underlying infrastructure.

7 investors

J-Pharma is a drug development company focused on SLC transporter-targeted therapies, with its lead LAT1 inhibitor nanvuranlat (JPH203) in a global Phase 3 trial for biliary tract cancer and other candidates addressing cancer, autoimmune, and rare diseases. The Tokyo-based biotech develops innovative small-molecule drugs and is listed on the Tokyo Stock Exchange Growth Market.

7 investors

STRM.BIO develops technology to deliver gene therapies, aiming to improve how these treatments reach patients. The company operates in the biotech sector, focused on advancing gene therapy for patients worldwide.

6 investors

1000Farmacie is an Italian online pharmacy and parapharmacy marketplace that aggregates products from over 60 partner pharmacies and other sellers, offering over 100,000 products for health and wellness including pharmaceuticals, medical devices, veterinary medicines, homeopathic and ayurvedic products, with home delivery across Italy.

6 investors

410 Medical makes LifeFlow, a hand-operated rapid infuser that lets clinicians quickly deliver blood or fluids to critically ill patients needing volume resuscitation. The device is aimed at hospital and emergency care settings for fluid resuscitation workflows.

6 investors

4baseCare delivers personalized cancer care using genomic data, AI analytics, and clinico-genomic datasets tailored to different populations. The company serves oncology patients and healthcare systems globally, focusing on precision medicine and treatment outcomes across diverse genetic backgrounds.

6 investors

64x develops infrastructure and manufacturing systems for next-generation medicines, focusing on genetic engineering, cell line development, and computational biology to enable scalability of advanced therapies.

6 investors

Aavia is a mobile app that helps people with ovaries track and understand how their hormones impact their health, mood, and productivity. The app provides personalized insights, science-backed recommendations, and educational content developed with reproductive health specialists.

6 investors

Abivax develops obefazimod, an orally administered small molecule drug candidate with a novel mechanism of action targeting microRNA biology to treat chronic inflammatory diseases including ulcerative colitis and Crohn's disease.

6 investors

AbleTo provides in-person and virtual mental health care, including therapy, psychiatry, and medication management for adults, children, and teens dealing with concerns such as anxiety, depression, ADHD, and substance use. It operates 150+ locations across the United States with over 1,200 therapists and psychiatrists, and accepts most insurance plans.

6 investors

A pharmaceutical company that develops medicines and vaccines for patients globally.

6 investors

Acclinate builds patient recruitment and data infrastructure for clinical research, connecting pharmaceutical companies with representative, diverse communities to improve research representation and health equity.

6 investors

Aclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases. The company's clinical and preclinical pipeline includes candidates in development for severe asthma, atopic dermatitis, and T-cell-mediated autoimmune conditions.

6 investors